Inducible transgene expression in mouse stem cells
David T Ting1, Michael Kyba, George Q Daley
1Harvard-M.I.T. Program in Health Sciences and Technology, Harvard Medical School. Boston, MA, USA.
Abstract:
Embryonic stem (ES) cells serve as a potentially unlimited source of cells and tissues to treat a number of genetic and malignant diseases. The differentiation of these cells into specific cell types is an area of very active investigation. One method of manipulating ES cell differentiation is through the alteration of gene expression. There are a multitude of different methods for expressing a target gene in ES cells, but most are limited in their ability to provide spatial, temporal, and quantitative control of gene expression. These properties are important because many developmentally interesting genes are regulated in at least one of these ways. This chapter will address these limitations through the use of an ES cell line with a doxycycline-inducible transgene system. A characterization of this inducible transgene system will be discussed, as well as the use of this system to develop ES-derived long-term engrafting hematopoietic stem cells. This demonstration is one of many possible uses for this powerful and versatile system.
Insights
Researchers developed a doxycycline-inducible system for precise control over gene expression in embryonic stem (ES) cells. This system enables the development of specific cell types, like hematopoietic stem cells, for potential disease treatments.
Area of Science:
- Stem cell biology
- Gene expression regulation
- Regenerative medicine
Background:
- Embryonic stem (ES) cells offer a potential source for cell and tissue therapies.
- Current methods for manipulating ES cell differentiation lack precise control over gene expression.
- Spatial, temporal, and quantitative control are crucial for studying developmental genes.
Purpose of the Study:
- To address limitations in controlling gene expression during ES cell differentiation.
- To introduce and characterize a doxycycline-inducible transgene system in ES cells.
- To demonstrate the system's utility in generating specific cell types for therapeutic applications.
Main Methods:
- Development of a doxycycline-inducible transgene system in an ES cell line.
- Characterization of the inducible transgene system's performance.
- Application of the system to derive ES-derived hematopoietic stem cells.
Main Results:
- Successful establishment of a doxycycline-inducible system in ES cells.
- Demonstration of controlled gene expression for ES cell differentiation.
- Generation of ES-derived long-term engrafting hematopoietic stem cells.
Conclusions:
- The doxycycline-inducible system provides robust spatial, temporal, and quantitative control over gene expression in ES cells.
- This versatile system facilitates the development of specific cell lineages, such as hematopoietic stem cells.
- The system holds significant potential for applications in regenerative medicine and disease modeling.
